Bluetongue Disease

• EMA guidance · 2013-06-07
  European Medicines Agency publishes interim fee advice for bluetongue-vaccine manufacturers

  EMA released interim fee advice for manufacturers of bluetongue vaccines, outlining anticipated fees and charging framework during the inter…

• EMA guidance · 2008-04-01
  European Medicines Agency to grant fee waivers to applications for bluetongue vaccines

  EMA announces that fee waivers will be granted for applications related to bluetongue vaccines.